Nxera Pharma Co (Nxera Pharma Co) Days Sales Outstanding : 95.72 (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Nxera Pharma Co Days Sales Outstanding?

Nxera Pharma Co's average Accounts Receivable for the three months ended in Mar. 2024 was $32.3 Mil. Nxera Pharma Co's Revenue for the three months ended in Mar. 2024 was $30.8 Mil. Hence, Nxera Pharma Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 95.72.

The historical rank and industry rank for Nxera Pharma Co's Days Sales Outstanding or its related term are showing as below:

SOLTF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 12.64 Med: 54.97 Max: 128.3
Current: 76.79

During the past 13 years, Nxera Pharma Co's highest Days Sales Outstanding was 128.30. The lowest was 12.64. And the median was 54.97.

SOLTF's Days Sales Outstanding is ranked worse than
53.48% of 892 companies
in the Biotechnology industry
Industry Median: 73.125 vs SOLTF: 76.79

Nxera Pharma Co's Days Sales Outstanding declined from Mar. 2023 (180.57) to Mar. 2024 (95.72).

Nxera Pharma Co Days Sales Outstanding Historical Data

The historical data trend for Nxera Pharma Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nxera Pharma Co Days Sales Outstanding Chart

Nxera Pharma Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

50.64

57.16

32.64

58.56

109.96

Nxera Pharma Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															180.57	151.95	91.14	55.38	95.72

Competitive Comparison of Nxera Pharma Co's Days Sales Outstanding

For the Biotechnology subindustry, Nxera Pharma Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nxera Pharma Co's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nxera Pharma Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Nxera Pharma Co's Days Sales Outstanding falls into.

Nxera Pharma Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Nxera Pharma Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (18.249	+	35.171)	/	2 )	/	88.664	*	365
=	26.71					/	88.664	*	365
=	109.96

Nxera Pharma Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (35.171	+	29.396)	/	2 )	/	30.777	*	365 / 4
=	32.2835					/	30.777	*	365 / 4
=	95.72

Nxera Pharma Co (OTCPK:SOLTF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Nxera Pharma Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Nxera Pharma Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Nxera Pharma Co (Nxera Pharma Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nxera Pharma Co Ltd (OTCPK:SOLTF) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

4565:Japan JSS:Germany

Address

2-1 Kojimachi, Chiyoda-ku, PMO Hanzomon 11th Floor, Tokyo, JPN, 102-0083

Website

http://www.sosei.com

Sosei Group Corp is an international biopharmaceutical company that develops treatments for a wide range of illnesses. The company utilizes its peptide platform technologies and nanotechnology to develop its product pipeline. Sosei actively seeks partnerships to aid its product development. The company's strategy for commercializing its therapies include utilizing its subsidiaries' drug discovery technologies, supplying technology to other companies, developing products in-house, and product licensing.